loading

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
Nov 26, 2024

Summit Therapeutics to Present at Upcoming Investor Conferences - BioSpace

Nov 26, 2024
pulisher
Nov 23, 2024

3 Monster Stocks in the Making - The Motley Fool

Nov 23, 2024
pulisher
Nov 21, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 21, 2024
pulisher
Nov 20, 2024

Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer? - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why - Insider Monkey

Nov 20, 2024
pulisher
Nov 18, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

(SMMT) Trading Report - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics - Investor's Business Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova - Reuters

Nov 14, 2024
pulisher
Nov 13, 2024

Has Summit Therapeutics Stock Already Peaked? - AOL

Nov 13, 2024
pulisher
Nov 12, 2024

2 Stocks Up Over 700% in 2024 That Could Soar Even Further - AOL

Nov 12, 2024
pulisher
Nov 11, 2024

2 Hot Biopharma Stocks to Buy and Hold for 5 Years - AOL

Nov 11, 2024
pulisher
Nov 09, 2024

BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential - Benzinga

Nov 09, 2024
pulisher
Nov 09, 2024

Is Summit Therapeutics a Millionaire Maker? - AOL

Nov 09, 2024
pulisher
Nov 08, 2024

Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Why Summit Therapeutics Stock Was a Winner Today - MSN

Nov 08, 2024
pulisher
Nov 06, 2024

Trading (SMMT) With Integrated Risk Controls - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 04, 2024

SMMT Surges as Analyst Initiates Coverage with Buy Rating - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Yahoo Finance UK

Nov 04, 2024
pulisher
Nov 04, 2024

Summit Therapeutics Leads the Parade of Big Gainers - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Summit Therapeutics shares rated Market Outperform by JMP Securities - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Summit Therapeutics Leads The Parade Of Big Gainers - Forbes

Nov 04, 2024
pulisher
Nov 04, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns Market Outperform Rating from Analysts at JMP Securities - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy? - MSN

Nov 04, 2024
pulisher
Nov 01, 2024

abrdn plc Invests $24.89 Million in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

H.C. Wainwright cuts Summit Therapeutics stock target, maintains Buy amid study expansion - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics (NASDAQ:SMMT) Price Target Cut to $44.00 by Analysts at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics reports Q3 EPS (5c), consensus (7c) - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insigh - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Summit Therapeutics Advances NSCLC Trials and Strengthens Financials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 10.4%What's Next? - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Summit Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024 - BioSpace

Oct 30, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Purchases 56,879 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Tesla, Xpeng, Summit Therapeutics lead Monday's morning market cap stock movers - Investing.com Australia

Oct 28, 2024
pulisher
Oct 28, 2024

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update - StockTitan

Oct 28, 2024
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):